Cramer says look to these 4 stocks to go with your high-flying tech names

On a recent broadcast, CNBC's Jim Cramer urged investors to broaden their horizons beyond the soaring tech sector and seek investment opportunities in areas that have experienced significant declines. He emphasized the importance of diversifying portfolios with stocks that are currently undervalued. Cramer highlighted concerns about the overheated state of the tech market, particularly following the recent peaks of the S&P 500 and Nasdaq Composite. He suggested that certain sectors, especially technology, could be at risk for sharp corrections. Instead, he pointed towards healthcare stocks that have been unfairly discounted despite their strong performance metrics. Among the overlooked companies he mentioned, CVS Health stood out due to its advantageous position in a shifting market landscape. With competitors like Rite Aid struggling and Walgreens reducing its footprint, Cramer believes CVS is poised to capture additional market share, supported by its expansive retail presence and insurance subsidiary, Aetna. Cramer also discussed Cardinal Health, which has suffered a drastic decline without justifiable cause, attributing its struggles to a broader market rotation away from healthcare. He noted the company’s strategic pivot towards higher-growth services that cater to specialized medical practices, positioning it for future success. Johnson & Johnson was another name on his radar, with Cramer praising its robust financial standing and promising pipeline of potential blockbuster drugs, making it a solid investment choice. Lastly, he mentioned UnitedHealth Group, which has recently reported strong earnings and benefited from the return of CEO Stephen Hemsley, contributing to renewed investor confidence in the company’s growth trajectory. Cramer's overarching message was clear: investors should aim for a balanced portfolio. With the tech sector riding high on an AI-fueled wave, he cautioned that a recalibration may soon be necessary to maintain stability and resilience in investment strategies.